Short Interest in Aurora Cannabis Inc. (NASDAQ:ACB) Expands By 6.8%

Aurora Cannabis Inc. (NASDAQ:ACB) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Based on an average daily volume of 1,030,000 shares, the short-interest ratio is presently 2.7 days. Approximately 5.2% of the company’s shares are short sold.

Aurora Cannabis Price Performance

ACB opened at $4.20 on Monday. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The company has a 50 day moving average of $5.52 and a two-hundred day moving average of $5.87. The company has a market cap of $230.33 million, a P/E ratio of -5.53 and a beta of 1.87. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07.

Hedge Funds Weigh In On Aurora Cannabis

Several hedge funds and other institutional investors have recently made changes to their positions in ACB. Cubist Systematic Strategies LLC purchased a new position in Aurora Cannabis in the second quarter valued at about $50,000. Cetera Advisors LLC acquired a new stake in shares of Aurora Cannabis in the first quarter valued at about $59,000. Toronto Dominion Bank raised its holdings in shares of Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after buying an additional 18,896 shares during the period. Baader Bank Aktiengesellschaft lifted its position in Aurora Cannabis by 121.1% during the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock worth $100,000 after acquiring an additional 12,481 shares in the last quarter. Finally, Mackenzie Financial Corp purchased a new position in Aurora Cannabis in the 2nd quarter worth approximately $113,000. Institutional investors and hedge funds own 47.63% of the company’s stock.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.